Skip to menu Skip to content Skip to footer

2024

Conference Publication

Oral contraceptives are strongly associated with an increased risk of irritable bowel syndrome but not functional dyspepsia among women in primary care

Koloski, Natasha, Jones, Michael, Shah, Ayesha, Holtmann, Gerald and Talley, Nicholas (2024). Oral contraceptives are strongly associated with an increased risk of irritable bowel syndrome but not functional dyspepsia among women in primary care. 5th Meeting of the Federation of Neurogastroenterology and Motility (FNM 2024), Bangkok, Thailand, 6 - 8 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/nmo.14902

Oral contraceptives are strongly associated with an increased risk of irritable bowel syndrome but not functional dyspepsia among women in primary care

2024

Journal Article

Diagnostic classification systems for disorders of gut‐brain interaction should include psychological symptoms

Jones, Michael P., Holtmann, Gerald J., Tack, Jan, Carbonne, Florencia, Chey, William, Koloski, Natasha, Shah, Ayesha, Bangdiwala, Shrikant I., Sperber, Ami D., Palsson, Olafur S. and Talley, Nicholas J. (2024). Diagnostic classification systems for disorders of gut‐brain interaction should include psychological symptoms. Neurogastroenterology & Motility, 36 (12) e14940, e14940. doi: 10.1111/nmo.14940

Diagnostic classification systems for disorders of gut‐brain interaction should include psychological symptoms

2024

Journal Article

The biogeography of the mucosa-associated microbiome in health and disease

Sternes, Peter R., Shah, Ayesha, Ayala Pintos, Camila, Fairlie, Thomas, Koloski, Natasha, Kang, Seungha, Tousignant, Kaylyn D., McIlroy, Simon J., Morrison, Mark, Tyson, Gene W. and Holtmann, Gerald J. (2024). The biogeography of the mucosa-associated microbiome in health and disease. Frontiers in Microbiology, 15 1454910, 1-14. doi: 10.3389/fmicb.2024.1454910

The biogeography of the mucosa-associated microbiome in health and disease

2024

Journal Article

The COVID‐19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta‐analysis

Kulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Wong, Reuben K., Fang, Xiucai, Ghoshal, Uday C., Kashyap, Purna C., Mulak, Agata, Lee, Yeong Yeh, Talley, Nicholas J., Koloski, Natasha, Jones, Michael P. and Holtmann, Gerald J. (2024). The COVID‐19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta‐analysis. Neurogastroenterology and Motility, 36 (10) e14878, 1-15. doi: 10.1111/nmo.14878

The COVID‐19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta‐analysis

2024

Conference Publication

Simethicone suppresses the growth of microbes cultured from the human duodenal mucosa

Fairlie, Thomas, Shah, Ayesha, Lim, Yenkai, Teh, Jing-Jie, Schooth, Lauren, Morrison, Mark and Holtmann, Gerald (2024). Simethicone suppresses the growth of microbes cultured from the human duodenal mucosa. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.

Simethicone suppresses the growth of microbes cultured from the human duodenal mucosa

2024

Conference Publication

The duodenal mucosa-associated microbiota differs in patients based on their Rome IV classification, and has variable effects on duodenal spheroid barrier function subjects

Schooth, Lauren, Burns, Grace, Minahan, Kyra, Teh, Jing-Jie, Fairlie, Tom, Shah, Ayesha, Holtmann, Gerald and Morrison, Mark (2024). The duodenal mucosa-associated microbiota differs in patients based on their Rome IV classification, and has variable effects on duodenal spheroid barrier function subjects. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.

The duodenal mucosa-associated microbiota differs in patients based on their Rome IV classification, and has variable effects on duodenal spheroid barrier function subjects

2024

Journal Article

A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut–brain interaction

Fairlie, Thomas, Shah, Ayesha, Wong, Reuben K., Fang, Xiucai, Ghoshal, Uday C., Kashyap, Purna C., Mulak, Agata, Lee, Yeong Yeh, Sperber, Ami D., Koloski, Natasha, Moy, Naomi, Talley, Nicholas J., Jones, Michael P. and Holtmann, Gerald (2024). A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut–brain interaction. Neurogastroenterology and Motility, 36 (9) e14866, 1-13. doi: 10.1111/nmo.14866

A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut–brain interaction

2024

Conference Publication

Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis

Khoo, Emi, Amiss, Anna, Lindsay, Niamh, Fernandes, Richard, Gilmore, Robert, Ding, John Nik, Connor, Susan J., Bryant, Robert, White, Lauren, Mohsen, Waled, Leong, Rupert, Ardalan, Zaid, Croft, Anthony, De Cruz, Peter, Lynch, Kate, An, Yoon-Kyo, Holtmann, Gerald and Begun, Jakob (2024). Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.

Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis

2024

Conference Publication

The biogeography of the mucosa-associated microbiota is associated with the presence and symptom severity of inflammatory bowel disease, proton pump inhibitor usage, and visceral sensitivity

Sternes, Peter, Shah, Ayesha, Pintos, Camila Ayela, Fairlie, Thomas, Koloski, Natasha, Kang, Seungha, Mcilroy, Simon, Morrison, Mark, Tyson, Gene and Holtmann, Gerald (2024). The biogeography of the mucosa-associated microbiota is associated with the presence and symptom severity of inflammatory bowel disease, proton pump inhibitor usage, and visceral sensitivity. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.

The biogeography of the mucosa-associated microbiota is associated with the presence and symptom severity of inflammatory bowel disease, proton pump inhibitor usage, and visceral sensitivity

2024

Conference Publication

Small intestinal bacterial overgrowth as assessed by breath testing: a prospective evaluation to the gold standard aspirate

Shah, Ayesha, Hansen, Teressa, Fairlie, Thomas, Koloski, Natasha, Jones, Mike and Holtmann, Gerald (2024). Small intestinal bacterial overgrowth as assessed by breath testing: a prospective evaluation to the gold standard aspirate. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.

Small intestinal bacterial overgrowth as assessed by breath testing: a prospective evaluation to the gold standard aspirate

2024

Conference Publication

Value based assessment of same day upper and lower endoscopy for patients referred for colonoscopy with a positive immunochemical feacal occult blood test

Shah, Ayesha, Moy, Naomi, Whaley, Amanda, Hansen, Teressa, Virgo, Kate, Dulleck, Uwe, Koloski, Natasha, Jones, Mike and Holtmann, Gerald (2024). Value based assessment of same day upper and lower endoscopy for patients referred for colonoscopy with a positive immunochemical feacal occult blood test. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.

Value based assessment of same day upper and lower endoscopy for patients referred for colonoscopy with a positive immunochemical feacal occult blood test

2024

Journal Article

Prevalence of small intestinal bacterial overgrowth in intestinal failure syndrome: A systematic review and meta‐analysis

Shah, Ayesha, Fairlie, Thomas, Morrison, Mark, Martin, Neal, Hammer, Karin, Hammer, Johann, Koloski, Natasha, Rezaie, Ali, Pimentel, Mark, Kashyap, Purna, Jones, Michael P. and Holtmann, Gerald (2024). Prevalence of small intestinal bacterial overgrowth in intestinal failure syndrome: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology, 39 (11), 1-11. doi: 10.1111/jgh.16668

Prevalence of small intestinal bacterial overgrowth in intestinal failure syndrome: A systematic review and meta‐analysis

2024

Journal Article

An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis

Shah, Ayesha, Tabibian, James, Buness, Cynthia and Holtmann, Gerald J. (2024). An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Digestive Diseases and Sciences, 69 (10), 1-6. doi: 10.1007/s10620-024-08497-4

An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis

2024

Conference Publication

Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis

Khoo, Emi, Amiss, Anna, Ding, Nik S., Bryant, Robert V., Mohsen, Waled, Connor, Susan J., Leong, Rupert, Croft, Anthony, Lynch, Kate D., Sparrow, Miles, De Cruz, Peter, An, Yoon-Kyo, Holtmann, Gerald J. and Begun, Jakob (2024). Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. Digestive Disease Week (DDW) 2024, Washington, DC, United States, 18-21 May 2024. Philadelphia, PA, United States: Elsevier. doi: 10.1016/s0016-5085(24)00988-0

Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis

2024

Journal Article

Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?

Shah, Ayesha and Holtmann, Gerald (2024). Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?. Alimentary Pharmacology and Therapeutics, 59 (10), 1290-1291. doi: 10.1111/apt.17990

Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?

2024

Conference Publication

Small Intestinal Bacterial Overgrowth As Assessed By Breath Testing: A Prospective Evaluation To The Gold Standard Aspirate

Hansen, Teressa J., Shah, Ayesha, Fairlie, Thomas, Koloski, Natasha A., Jones, Michael P. and Holtmann, Gerald J. (2024). Small Intestinal Bacterial Overgrowth As Assessed By Breath Testing: A Prospective Evaluation To The Gold Standard Aspirate. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)00876-x

Small Intestinal Bacterial Overgrowth As Assessed By Breath Testing: A Prospective Evaluation To The Gold Standard Aspirate

2024

Conference Publication

Small Intestinal Bacterial Overgrowth In Intestinal Failure: A Systematic Review And Meta-analysis

Fairlie, Thomas, Shah, Ayesha, Martin, Neal, Jones, Michael P., Koloski, Natasha A., Morrison, Mark and Holtmann, Gerald J. (2024). Small Intestinal Bacterial Overgrowth In Intestinal Failure: A Systematic Review And Meta-analysis. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)02701-x

Small Intestinal Bacterial Overgrowth In Intestinal Failure: A Systematic Review And Meta-analysis

2024

Conference Publication

Small Intestinal Bacterial Overgrowth In Chronic Liver Disease: An Updated Systematic Review And Meta-analysis Of Case-control Studies

Shah, Ayesha, Spannenburg, Liam, Thite, Parag, Fairlie, Thomas, Koloski, Natasha A., Morrison, Mark, Jones, Michael P. and Holtmann, Gerald J. (2024). Small Intestinal Bacterial Overgrowth In Chronic Liver Disease: An Updated Systematic Review And Meta-analysis Of Case-control Studies. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)02706-9

Small Intestinal Bacterial Overgrowth In Chronic Liver Disease: An Updated Systematic Review And Meta-analysis Of Case-control Studies

2024

Conference Publication

Diagnostic Classification Systems For Disorders Of Gut-brain Interaction Should Include Psychological Symptoms

Jones, Michael P., Holtmann, Gerald J., Tack, Jan F., Carbone, Florencia, Chey, William D., Koloski, Natasha A., Shah, Ayesha, Bangdiwala, Shrikant I., Sperber, Ami D., Palsson, Olafur S. and Talley, Nicholas J. (2024). Diagnostic Classification Systems For Disorders Of Gut-brain Interaction Should Include Psychological Symptoms. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)01601-9

Diagnostic Classification Systems For Disorders Of Gut-brain Interaction Should Include Psychological Symptoms

2024

Conference Publication

The Duodenal Mucosa-associated Microbiota Of Patients With A Disorder Of Gut-brain Interaction Can Be Differentiated By Rome IV Criteria

Schooth, Lauren F., Kang, Seungha, Fairlie, Thomas, Lim, Yenkai, Teh, Jing Jie, Hoedt, Emily C., Keely, Simon, Shah, Ayesha, Holtmann, Gerald J. and Morrison, Mark (2024). The Duodenal Mucosa-associated Microbiota Of Patients With A Disorder Of Gut-brain Interaction Can Be Differentiated By Rome IV Criteria. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)02266-2

The Duodenal Mucosa-associated Microbiota Of Patients With A Disorder Of Gut-brain Interaction Can Be Differentiated By Rome IV Criteria